<DOC>
	<DOC>NCT01518894</DOC>
	<brief_summary>To evaluate the safety and tolerability of multiple, ascending doses of PF-04958242 administered orally to psychiatrically stable subjects with schizophrenia receiving antipsychotic and adjunctive medication.</brief_summary>
	<brief_title>A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Psychiatrically Stable Subjects With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Psychiatrically stable subjects with schizophrenia Evidence of stable schizophrenia symptomatology â‰¥ 3 months Score on MCCB Letternumber span + Spatial span subtest &lt; 40. History of seizures or of a condition with risk of seizures History of abnormal EEG. Pregnant or nursing females, and women of child bearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>PF-04958242</keyword>
	<keyword>multiple dose</keyword>
	<keyword>Safety</keyword>
	<keyword>schizophrenia</keyword>
</DOC>